SCHEMBL722135

SCHEMBL722135

CCC(C)OP(=O)(O)C(Cc1ccc(F)cc1)c1sc2ccccc2c1Br

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.52
PTGS2 P35354 3/20 0.41
CASP3 P42574 4/20 0.34
CASP7 P55210 2/20 0.34
MAPT P10636 1/20 0.34
PTPN1 P18031 1/20 0.34
TRPA1 O75762 1/20 0.32
EPHX2 P34913 1/20 0.32
PPARG P37231 1/20 0.32
CYP2D6 P10635 1/20 0.31
CHRM1 P11229 1/20 0.31
HTR2A P28223 1/20 0.31
HRH1 P35367 1/20 0.31
ACP3 P15309 3/20 0.31
PRNP P04156 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
TP53 P04637 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL716713 0.90 TRPM8 (0.41) TRPM8PTGS2CASP3CASP7MAPT
SCHEMBL5051479 0.89 TRPM8 (0.58) TRPM8PTGS2
SCHEMBL718590 0.88 TRPM8 (0.50) TRPM8PTGS2EPHX2PPARG
SCHEMBL717137 0.88 TRPM8 (0.56) TRPM8PTGS2
SCHEMBL717609 0.85 TRPM8 (0.49) TRPM8PTGS2CASP3CASP7PTPN1
SCHEMBL717281 0.83 TRPM8 (0.49) TRPM8PTGS2CASP3CASP7MAPT
SCHEMBL715490 0.83 TRPM8 (0.47) TRPM8PTGS2MAPTACP3
SCHEMBL717008 0.83 TRPM8 (0.51) TRPM8PTGS2CASP3CASP7MAPT
SCHEMBL718484 0.83 TRPM8 (0.51) TRPM8PTGS2CASP3CASP7MAPT
SCHEMBL718483 0.82 TRPM8 (0.72) TRPM8PTGS2CASP3CASP7MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090639-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA N.V. (BE) 2015-07-28 US disclosed
US-20140100194-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA, NV (BE) 2014-04-10 US disclosed
US-8629281-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA, NV (BE) 2014-01-14 US disclosed
US-8558011-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA, NV (BE) 2013-10-15 US disclosed
EP-2029614-B1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2013-01-23 EP disclosed
US-20120184510-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS COLBURN RAYMOND W (US) 2012-07-19 US disclosed
US-20120053347-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2012-03-01 US disclosed
US-7897781-B2 Cold menthol receptor-1 antagonists JANSSEN PHARMACEUTICA NV (BE) 2011-03-01 US disclosed
US-20080287398-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-11-20 US disclosed
US-20080027029-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027029-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885CASP3 3715/4885
US-20120184510-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885CASP3 3715/4885
US-20120053347-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885CASP3 3715/4885
US-20080287398-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885CASP3 3715/4885
US-20140100194-A1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS TRPM8, TRPM5, TRPM7 TRPM8 1/4885PTGS2 909/4885CASP3 3715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.